WallStreetZenWallStreetZen

NASDAQ: INCR
Intercure Ltd Stock

$2.71+0.18 (+7.11%)
Updated Mar 28, 2024
INCR Price
$2.71
Fair Value Price
N/A
Market Cap
$123.50M
52 Week Low
$0.99
52 Week High
$2.87
P/E
N/A
P/B
0.92x
P/S
0.69x
PEG
N/A
Dividend Yield
N/A
Revenue
$109.73M
Earnings
$4.39M
Gross Margin
33.5%
Operating Margin
6.01%
Profit Margin
3.9%
Debt to Equity
0.62
Operating Cash Flow
N/A
Beta
0.86
Next Earnings
Apr 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

INCR Overview

Intercure Limited produces and distributes medical cannabis products in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed industries. InterCure was incorporated in 1994 and is headquartered in Herzliya, Israel.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how INCR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

INCR is good value based on its book value relative to its share price (0.92x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.19x)
P/B vs Industry Valuation
INCR's profit margin has decreased (-4.3%) in the last year from (8.2%) to (3.9%)
Profit Margin Growth Financials
INCR's short-term assets ($104.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more INCR due diligence checks available for Premium users.

Be the first to know about important INCR news, forecast changes, insider trades & much more!

INCR News

Valuation

INCR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0x
Industry
54.21x
Market
44.51x

INCR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.92x
Industry
2.19x
INCR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

INCR's financial health

Profit margin

Revenue
$27.8M
Net Income
$629.5k
Profit Margin
2.3%
INCR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$228.1M
Liabilities
$85.1M
Debt to equity
0.62
INCR's short-term assets ($104.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INCR's short-term assets ($104.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INCR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A

INCR vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
INCR$123.50M+7.11%N/A0.92x
CRDL$117.28M+0.56%-5.80x4.64x
EBS$132.07M-2.32%-0.17x0.20x
SCTL$114.15M-0.92%-7.71x1.95x
FTLF$109.28M+0.04%25.06x4.33x

Intercure Stock FAQ

What is Intercure's quote symbol?

(NASDAQ: INCR) Intercure trades on the NASDAQ under the ticker symbol INCR. Intercure stock quotes can also be displayed as NASDAQ: INCR.

If you're new to stock investing, here's how to buy Intercure stock.

What is the 52 week high and low for Intercure (NASDAQ: INCR)?

(NASDAQ: INCR) Intercure's 52-week high was $2.87, and its 52-week low was $0.99. It is currently -5.51% from its 52-week high and 173.74% from its 52-week low.

How much is Intercure stock worth today?

(NASDAQ: INCR) Intercure currently has 45,572,709 outstanding shares. With Intercure stock trading at $2.71 per share, the total value of Intercure stock (market capitalization) is $123.50M.

Intercure stock was originally listed at a price of $6.75 in Sep 1, 2021. If you had invested in Intercure stock at $6.75, your return over the last 2 years would have been -59.85%, for an annualized return of -36.64% (not including any dividends or dividend reinvestments).

How much is Intercure's stock price per share?

(NASDAQ: INCR) Intercure stock price per share is $2.71 today (as of Mar 28, 2024).

What is Intercure's Market Cap?

(NASDAQ: INCR) Intercure's market cap is $123.50M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Intercure's market cap is calculated by multiplying INCR's current stock price of $2.71 by INCR's total outstanding shares of 45,572,709.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.